{ "@graph": [    { "@id": "http://linked.opendata.cz/resource/ATC/N",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/ATCConcept" ] ,      "http://purl.org/dc/terms/title" : [ { "@value" : "Nervov\u00FD syst\u00E9m" , "@language" : "cs" } ,        { "@value" : "NERVOUS SYSTEM" , "@language" : "en" } ] ,      "http://www.w3.org/2004/02/skos/core#notation" : [ { "@value" : "N" } ] } ,    { "@id": "http://linked.opendata.cz/resource/ATC/N04",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/ATCConcept" ] ,      "http://purl.org/dc/terms/title" : [ { "@value" : "ANTI-PARKINSON DRUGS" , "@language" : "en" } ,        { "@value" : "Antiparkinsonika" , "@language" : "cs" } ] ,      "http://www.w3.org/2004/02/skos/core#notation" : [ { "@value" : "N04" } ] } ,    { "@id": "http://linked.opendata.cz/resource/ATC/N04B",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/ATCConcept" ] ,      "http://purl.org/dc/terms/title" : [ { "@value" : "Dopaminergn\u00ED l\u00E9\u010Diva" , "@language" : "cs" } ,        { "@value" : "DOPAMINERGIC AGENTS" , "@language" : "en" } ] ,      "http://www.w3.org/2004/02/skos/core#notation" : [ { "@value" : "N04B" } ] } ,    { "@id": "http://linked.opendata.cz/resource/ATC/N04BA",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/ATCConcept" ] ,      "http://purl.org/dc/terms/title" : [ { "@value" : "Dopa a jej\u00ED deriv\u00E1ty" , "@language" : "cs" } ,        { "@value" : "Dopa and dopa derivatives" , "@language" : "en" } ] ,      "http://www.w3.org/2004/02/skos/core#notation" : [ { "@value" : "N04BA" } ] } ,    { "@id": "http://linked.opendata.cz/resource/ATC/N04BA02",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/ATCConcept" ] ,      "http://www.w3.org/2004/02/skos/core#broaderTransitive" : [ "http://linked.opendata.cz/resource/ATC/N" ,        "http://linked.opendata.cz/resource/ATC/N04B" ,        "http://linked.opendata.cz/resource/ATC/N04BA" ,        "http://linked.opendata.cz/resource/ATC/N04" ] ,      "http://purl.org/dc/terms/title" : [ { "@value" : "Levodopa and decarboxylase inhibitor" , "@language" : "en" } ,        { "@value" : "Levodopa a inhibitor dekarboxyl\u00E1zy" , "@language" : "cs" } ] ,      "http://www.w3.org/2004/02/skos/core#notation" : [ { "@value" : "N04BA02" } ] } ,    { "@id": "http://linked.opendata.cz/resource/ndfrt/disease/N0000000999",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/DiseaseOrFinding" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/title" : [ { "@value" : "Drug hypersensitivity" , "@language" : "en" } ,        { "@value" : "L\u00E9kov\u00E1 alergie" , "@language" : "cs" } ] } ,    { "@id": "http://linked.opendata.cz/resource/ndfrt/disease/N0000003321",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/DiseaseOrFinding" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/title" : [ { "@value" : "Glaukom s uzav\u0159en\u00FDm \u00FAhlem" , "@language" : "cs" } ,        { "@value" : "Glaucoma, angle-closure" , "@language" : "en" } ] } ,    { "@id": "http://linked.opendata.cz/resource/ndfrt/disease/N0000001969",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/DiseaseOrFinding" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/title" : [ { "@value" : "Melanoma" , "@language" : "en" } ,        { "@value" : "Melanom" , "@language" : "cs" } ] } ,    { "@id": "http://linked.opendata.cz/resource/drug-encyclopedia/ingredient/M0012434",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/Ingredient" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/title" : [ { "@value" : "Levodopa" , "@language" : "cs" } ,        { "@value" : "Levodopa" , "@language" : "en" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasPharmacologicalAction" : [ "http://linked.opendata.cz/resource/drug-encyclopedia/pharmacological-action/M0023499" ,        "http://linked.opendata.cz/resource/drug-encyclopedia/pharmacological-action/M0001494" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/description" : [ { "@value" : "The naturally occurring form of DIHYDROXYPHENYLALANINE and the immediate precursor of DOPAMINE. Unlike dopamine itself, it can be taken orally and crosses the blood-brain barrier. It is rapidly taken up by dopaminergic neurons and converted to DOPAMINE. It is used for the treatment of PARKINSONIAN DISORDERS and is usually given with agents that inhibit its conversion to dopamine outside of the central nervous system.     " , "@language" : "en" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/contraindicatedWith" : [ "http://linked.opendata.cz/resource/ndfrt/disease/N0000000999" ,        "http://linked.opendata.cz/resource/ndfrt/disease/N0000001969" ,        "http://linked.opendata.cz/resource/ndfrt/disease/N0000003321" ] } ,    { "@id": "http://linked.opendata.cz/resource/datamart/drug-encyclopedia/ingredient/sukl/0005580",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/Ingredient" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/title" : [ { "@value" : "Benserazide hydrochloride" , "@language" : "en" } ,        { "@value" : "Benserazid-hydrochlorid" , "@language" : "cs" } ,        { "@value" : "Benserazidi hydrochloridum" , "@language" : "la" } ] } ,    { "@id": "http://linked.opendata.cz/resource/sukl/medicinal-product/MADOPAR-62-5",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/MedicinalProduct" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasActiveIngredient" : [ "http://linked.opendata.cz/resource/datamart/drug-encyclopedia/ingredient/sukl/0005580" ,        "http://linked.opendata.cz/resource/drug-encyclopedia/ingredient/M0012434" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/title" : [ { "@value" : "MADOPAR 62,5" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasATCConcept" : [ "http://linked.opendata.cz/resource/ATC/N04BA02" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasMedicinalProductPackaging" : [ "http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0016044" ] } ,    { "@id": "http://linked.opendata.cz/resource/drug-encyclopedia/pharmacological-action/M0001494",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/PharmacologicalAction" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/title" : [ { "@value" : "Antiparkinsonika" , "@language" : "cs" } ,        { "@value" : "Antiparkinson agents" , "@language" : "en" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/description" : [ { "@value" : "Agents used in the treatment of Parkinson's disease. The most commonly used drugs act on the dopaminergic system in the striatum and basal ganglia or are centrally acting muscarinic antagonists.     " , "@language" : "en" } ] } ,    { "@id": "http://linked.opendata.cz/resource/drug-encyclopedia/pharmacological-action/M0023499",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/PharmacologicalAction" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/title" : [ { "@value" : "Dopamine agents" , "@language" : "en" } ,        { "@value" : "Dopaminov\u00E9 l\u00E1tky" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/description" : [ { "@value" : "Any drugs that are used for their effects on dopamine receptors, on the life cycle of dopamine, or on the survival of dopaminergic neurons.     " , "@language" : "en" } ] } ,    { "@id": "http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0016044",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/MedicinalProductPackaging" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/title" : [ { "@value" : "MADOPAR 62,5" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasATCConcept" : [ "http://linked.opendata.cz/resource/ATC/N04BA02" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasIndicationGroup" : [ { "@value" : "ANTIPARKINSONICA" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasSPCDocument" : [ "http://linked.opendata.cz/resource/sukl/spc/document/SPC160083_doc" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasPackagingSize" : [ { "@value" : "100" , "@type" : "http://www.w3.org/2001/XMLSchema#string" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasRouteOfAdministration" : [ { "@value" : "Peror\u00E1ln\u00ED pod\u00E1n\u00ED" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasStrength" : [ { "@value" : "62.5MG" , "@type" : "http://www.w3.org/2001/XMLSchema#string" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasIndication" : [ { "@value" : "Parkinsonova nemoc\nMadopar 62,5 je indikov\u00E1n k l\u00E9\u010Db\u011B (zm\u00EDrn\u011Bn\u00ED symptom\u016F) parkinsonismu u idiopatick\u00E9 Parkinsonovy nemoci. D\u00E1le m\u016F\u017Ee \u010D\u00E1ste\u010Dn\u011B zm\u00EDrnit p\u0159\u00EDznaky sekund\u00E1rn\u00EDho parkinsonsk\u00E9ho syndromu po encefalitid\u00E1ch, intoxikac\u00EDch (nap\u0159. po otrav\u011B CO) a\u00A0u\u00A0parkinsonismu v d\u016Fsledku mozkov\u00E9 arterioskler\u00F3zy. Madopar 62,5 je ur\u010Den pro stavy s dysfagi\u00ED a pro stavy vy\u017Eaduj\u00EDc\u00ED rychl\u00FD n\u00E1stup \u00FA\u010Dinku, tj. pro pacienty s \u010Dasnou rann\u00ED a odpoledn\u00ED akinez\u00ED a u pacient\u016F s \u201Edelayed-on\u201C \u010Di \u201Ewearing-off\u201C (syndrom z odezn\u011Bn\u00ED) fenomeny.\nSyndrom neklidn\u00FDch nohou (RLS)\nMadopar je d\u00E1le ur\u010Den k symptomatick\u00E9 l\u00E9\u010Db\u011B syndromu neklidn\u00FDch nohou (RLS) v\u010Detn\u011B idiopatick\u00E9ho RLS a k terapii RLS u dialyzovan\u00FDch pacient\u016F s\u00A0ren\u00E1ln\u00EDm selh\u00E1n\u00EDm. \n" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasRegistrationState" : [ "http://linked.opendata.cz/resource/sukl/registration-state/R" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasMaximalPrice" : [ { "@value" : 236.4199981689453 , "@type" : "http://www.w3.org/2001/XMLSchema#float" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasReimbursementAmount" : [ { "@value" : 279.5199890136719 , "@type" : "http://www.w3.org/2001/XMLSchema#float" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasTitleSupplement" : [ { "@value" : "POR TBL SOL 100X62.5MG" , "@language" : "cs" } ] }] }